FDA told advisers drug to be rejected
Posted: December 27, 2012 at 12:56 a.m.
Three members of an independent advisory panel say they received as much as a day’s notice in May 2010 before U.S. regulators rejected a drug from Inter-Mune Inc., now tied to an insider-trading probe of SAC Capital Advisors LP.
This story is only available from our archives.
Business, Pages 19 on 12/27/2012
(Advertisement)
« Previous Story
Sales less merry, bright than retailers had h...
Shoppers spent cautiously this Christmas, a disappointment for retailers who slashed prices to lure people int... Read »
Next Story »
Stocks slide on slow Christmas sales
U.S. stocks fell Wednesday for the third trading day in a row. Disappointing holiday sales weighed heavily on retail companies, and the unwelcome “fiscal cliff” package of ... Read »

Comments
To report abuse or misuse of this area please hit the "Suggest Removal" link in the comment to alert our online managers. Please read our comment policy.
Use the comment form below to begin a discussion about this content.
Registration is required to make comments. Click here to LOGIN.
You can register for FREE to post comments and receive alerts.